The effect of Maoljobon ( whey) on Cancer patients with chemotherapy induced hand and foot syndrome
Phase 3
- Conditions
- Chemotherapy-induced hand and foot syndrome.
- Registration Number
- IRCT20220317054317N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients over 18 years of age with hand syndrome and reason for chemotherapy, from Capecitabine, who are willing to participate in the study.
Exclusion Criteria
Patients with other skin lesions - Infection - Inflammatory bowel disease - History of severe milk allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of pain in the lesions. Timepoint: Before the intervention, one day and one week after the intervention period. Method of measurement: visual analog scale.;Degree of waste. Timepoint: Before the intervention, one day and one week after the intervention period. Method of measurement: Common Terminology Criteria for Adverse Event.;The amount of burning and itching and numbness of the lesions. Timepoint: Before the intervention, one day and one week after the intervention period. Method of measurement: Likert Questionnaire.;Scaling rate and redness of the lesions. Timepoint: Before the intervention, one day and one week after the intervention period. Method of measurement: Dermatologist photography and opinion.
- Secondary Outcome Measures
Name Time Method Overall quality of life. Timepoint: before the intervention and one day and one week after the intervention period. Method of measurement: (Quality of Life)questionnaire.;Quality of life of a skin patient. Timepoint: before the intervention and one day and one week after the intervention period. Method of measurement: Dermatology Life Quality Index questionnaire.